"During my decade at Illumina Ventures, I evaluated countless genomics innovations, yet Arima’s approach stands out for its ability to illuminate aspects of the genome most tests never see," said ...
CARLSBAD, Calif., April 10, 2025--(BUSINESS WIRE)--Arima Genomics, Inc. (Arima), a company leveraging 3D genomics to reveal actionable insights that will empower researchers and clinicians to improve ...
SAN DIEGO--(BUSINESS WIRE)--Arima Genomics, Inc., the leader in 3D genomics, today announced the close of its $7 million Series B Preferred Stock financing round. New investors Genetron Health (NASDAQ ...
SAN DIEGO--(BUSINESS WIRE)--Arima Genomics, Inc., a company focused on research tools to accelerate the understanding of genome sequence and structure toward their role in human health and disease, ...
Arima Genomics, Inc., a company leveraging 3D genomics to reveal actionable insights to improve human health and drive discovery in the life sciences, today announced the formation of a clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results